3D printing drugs? Oh, the possibilities.

The FDA recently approved the first 3D printed drug – SPRITAM® levetiracetam for oral use as a prescription adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy. Aprecia Pharmaceuticals, the developer of the drug, devised a way of producing individually dosed tablets that dissolve on contact with liquid.

“ZipDose Technology enables the delivery of a high drug load, up to 1,000 mg in a single dose.2 As a result, SPRITAM enhances the patient experience – administration of even the largest strengths of levetiracetam with just a sip of liquid. In addition, with SPRITAM there is no measuring required as each dose is individually packaged, making it easy to carry this treatment on the go.”

Full article here: http://tinyurl.com/p49pard

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: